PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatocellular carcinoma |
| Symptom | |cirrhosis |
| Sentences | 144 |
| PubMedID- 23904843 | The greatest advantage of pure laparoscopic hepatectomy for hepatocellular carcinoma with concomitant liver cirrhosis is that postoperative ascites retention is minimal, meaning that there is little risk of water-electrolyte imbalance associated with ascites retention or hypoproteinemia. |
| PubMedID- 22941170 | Background: initial therapy for early hepatocellular carcinoma (hcc) with well-compensated cirrhosis is controversial. |
| PubMedID- 22606287 | Ald-associated disorders include fatty liver, inflammation, and hepatocellular carcinoma in patients with liver cirrhosis . |
| PubMedID- 25436303 | As hepatocellular carcinoma is often associated with liver cirrhosis, patients are at risk for postoperative liver failure. |
| PubMedID- 25091611 | hepatocellular carcinoma (hcc)-closely associated with liver cirrhosis and, in fact, the main cause of death in patients with such disease-is now recognized as one of the most-prevalent and lethal neoplasms worldwide. |
| PubMedID- 20857114 | Purpose: we have previously shown that continuous intra-arterial combination chemotherapy (iacc) might be more effective for advanced hepatocellular carcinoma (ahcc) in patients with hcv-related liver cirrhosis (c-lc) or alcoholic liver cirrhosis (a-lc) than in patients with hbv-related lc (b-lc). |
| PubMedID- 22232996 | Accuracy of multislice computed tomography in the diagnosis of hepatocellular carcinoma in patients with cirrhosis evaluated for liver transplantation. |
| PubMedID- 23372775 | In china, approximately 40 million people are infected with hcv 5, and it is estimated that 50% to 85% of all individuals infected with hcv develop chronic hepatitis; of these patients, 20% to 30% progress to liver cirrhosis that may lead to hepatocellular carcinoma (hcc). |
| PubMedID- 20578139 | Surveillance for hepatocellular carcinoma (hcc) in patients with cirrhosis is recommended but may not be performed. |
| PubMedID- 25544499 | Infection with hepatitis c virus (hcv), a major viral cause of chronic liver disease, frequently progresses to steatosis and cirrhosis, which can lead to hepatocellular carcinoma. |
| PubMedID- 21896165 | In 40-60% of hcv-infected individuals, chronic infection is mainly associated with liver cirrhosis and steatosis, leading to hepatocellular carcinoma (hcc) . |
| PubMedID- 21520172 | For patients who have cirrhosis with hepatocellular carcinoma (hcc), living donor liver transplantation (ldlt) reduces waiting time and dropout rates. |
| PubMedID- 21663667 | About 75% of patients achieve no therapeutic benefit from the present combination therapy with pegylated interferon α (peg-ifn-α) and ribavirin mainly depending upon hcv genotype, whereas in 40-60% patients chronic infection is mainly associated with liver cirrhosis and steatosis leading to hepatocellular carcinoma (hcc) . |
| PubMedID- 20831903 | Background & aims: there are few data available about the prevalence or effects of cirrhosis in patients with hepatocellular carcinoma (hcc) from viral hepatitis. |
| PubMedID- 22723858 | Besides emphysema, the z aat variant also predisposes to liver diseases, which may present in zz homozygous individuals as neonatal jaundice, cirrhosis and increased risk of hepatocellular carcinoma 7. |
| PubMedID- 25330059 | Liver resection for hepatocellular carcinoma (hcc) combined with nash-related cirrhosis has become increasingly common. |
| PubMedID- 24815863 | Because cirrhosis underlies most cases of hepatocellular carcinoma (hcc) and advanced cirrhosis can, in fact, affect patients’ survival to a greater degree than the carcinoma itself (3,4), the ctp score has become the standard prognostic tool for predicting survival and for assessing hepatic reserve to guide initial or subsequent therapy decisions by predicting risk of liver failure and death after local and systemic therapies and for categorizing patients under hcc staging systems for trial entry (5). |
| PubMedID- 20505515 | Metabolic risk factors are a major comorbidity in patients with cirrhosis independent of the presence of hepatocellular carcinoma. |
| PubMedID- 24634946 | Background/aims: type b and c hepatic cirrhosis are main causes of hepatocellular carcinoma (hcc). |
| PubMedID- 24949326 | We recently experienced a case of ldlt for hepatocellular carcinoma combined with liver cirrhosis secondary to hepatitis b virus and hepatitis c virus infection. |
| PubMedID- 21881927 | Of the remaining ten patients, four had hepatitis c-related cirrhosis (one also with hepatocellular carcinoma), three had alcoholic cirrhosis, two had primary biliary cirrhosis, and one had non-alcoholic, fatty liver disease-associated cirrhosis. |
| PubMedID- 25785114 | Risk factors for naturally-occurring early-onset hepatocellular carcinoma in patients with hbv-associated liver cirrhosis in china. |
| PubMedID- 26155045 | hepatocellular carcinoma without cirrhosis presenting with hypercalcemia: case report and literature review. |
| PubMedID- 22902757 | Background & aims: we aimed to identify risk factors for hepatocellular carcinoma (hcc) in patients with cirrhosis in the united states. |
| PubMedID- 24919730 | Liver transplant is the preferred treatment for hepatocellular carcinoma in patients with cirrhosis, as both neoplastic and cirrhotic liver tissue can be removed. |
| PubMedID- 21176666 | Peri-operative treatment for hepatocellular carcinoma patients complied with cirrhosis and hypersplenism. |
| PubMedID- 23732780 | Influence of etiology on host immunity in liver cirrhosis patients with advanced hepatocellular carcinoma receiving intra-arterial chemotherapy. |
| PubMedID- 25963509 | New evidence shows that statins improve response to interferon-based anti-hcv therapy, decrease progression to cirrhosis and likelihood of developing hepatocellular carcinoma. |
| PubMedID- 25212123 | Whether preoperative clinically significant portal hypertension (csph) has or not an impact on the outcome of surgery for hepatocellular carcinoma (hcc) in patients with compensated cirrhosis is debated. |
| PubMedID- 25138286 | Purpose: the aim of this retrospective cohort study was to clarify the effect of a branched-chain amino acids (bcaa) on the liver function and the prognosis of child-pugh class (c-p) a and b liver cirrhosis (lc) patients with advanced hepatocellular carcinoma (ahcc) undergoing hepatic arterial infusion chemotherapy (haic). |
| PubMedID- 22013259 | The first patient was a 45-year-old male hepatitis c related cirrhosis with hepatocellular carcinoma, child grade c, with refractory ascites, coagulopathy and mild hepatorenal syndrome. |
| PubMedID- 25513088 | As hepatocellular carcinoma is often associated with liver cirrhosis, patients are at risk for postoperative liver failure. |
| PubMedID- 21388559 | In 40-60% of hcv-infected individuals, persistent infection is mainly associated with liver cirrhosis and steatosis, leading to hepatocellular carcinoma (hcc) . |
| PubMedID- 26215124 | The aim of this study was to characterize the immune status of hcv-related cirrhosis in patients with hepatocellular carcinoma (hcv-hcc) as compared to hcv patients without hepatocellular carcinoma. |
| PubMedID- 23519837 | Purpose: detection, characterization, and monitoring the treatment of hepatocellular carcinomas (hcc) in patients with cirrhosis is challenging because of their variable and rapid arterial enhancement. |
| PubMedID- 23431294 | Simple steatosis, or fatty liver, occurs early in nafld and may progress to nonalcoholic steatohepatitis (nash), fibrosis, and cirrhosis with increased risk of hepatocellular carcinoma . |
| PubMedID- 23304671 | Hbv subgenotype c2 infection, a1762t/g1764a mutations may contribute to hepatocellular carcinoma with cirrhosis in southeast china. |
| PubMedID- 26442209 | Between 60 and 90% of hepatocellular carcinoma occur in patients with hepatic macronodular cirrhosis (18, 19). |
| PubMedID- 23696887 | cirrhosis precedes most cases of hepatocellular carcinoma (hcc), with 70%–90% of hcc developing from a background of chronic liver cirrhosis 4. |
| PubMedID- 25963079 | Using seldi-tof ms, serum protein/peptide profiles on the cm10 proteinchip arrays were obtained from a training group including 26 hbv-associated hepatocellular carcinoma patients with liver cirrhosis (lc), 30 hbv-associated lc patients, 85 patients at different stages of liver fibrosis, and 30 asymptomatic hbv carriers. |
| PubMedID- 25335877 | Purpose: the aim of this study was to construct a prediction model for posthepatectomy liver failure (phlf), as defined by the international study group of liver surgery, and evaluate its accuracy in hepatocellular carcinoma (hcc) patients with cirrhosis or chronic hepatitis. |
| PubMedID- 23000435 | We report the case and discuss the outcome of a 63-year-old man, who was transplanted for hepatocellular carcinoma arising from cirrhosis associated with non-alcoholic fatty liver and diabetes. |
| PubMedID- 24636295 | Objective: to investigate the role of absent ductular reaction (dr) at hepatocellular-stromal boundaries in early stage hepatocellular carcinoma (hcc) with cirrhosis in patients with chronic hepatitis b. |
| PubMedID- 19762191 | So far, the available data suggest that iron accumulation in the liver is an independent risk factor for hepatocellular carcinoma in patients with alcoholic cirrhosis and/or nonalcoholic hepatosteatosis, but not in those with viral hepatitis c cirrhosis. |
| PubMedID- 20517910 | All the patients had hepatitis b virus-related cirrhosis with hepatocellular carcinoma. |
| PubMedID- 20487573 | Serum egf levels were 1.8-fold higher in g/g hepatocellular carcinoma patients with cirrhosis than a/a patients, and liver egf levels were 2.4-fold higher in g/g patients than a/a patients. |
| PubMedID- 23768738 | Background: liver resection for hepatocellular carcinoma (hcc) combined with nash -related cirrhosis has become increasingly common. |
| PubMedID- 21371325 | Background: occult hbv infection accelerates the progression of liver fibrosis, cirrhosis, and finally leading to hepatocellular carcinoma (hcc). |
| PubMedID- 25961631 | Imaging features and prognosis of hepatocellular carcinoma in patients with cirrhosis who are coinfected with human immunodeficiency virus and hepatitis c virus. |
| PubMedID- 25524812 | Background & aims: surveillance for hepatocellular carcinoma (hcc) in patients with cirrhosis is recommended in clinical guidelines. |